Skip to main content
Clinical Trials/DRKS00023068
DRKS00023068
Completed
未知

Effects of a specific task oriented training versus its combination with manual therapy on balance and mobility in people post stroke at the chronic stage - SATMANT

Therapiezentrum Kinema0 sites36 target enrollmentSeptember 21, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke at the chronic stage
Sponsor
Therapiezentrum Kinema
Enrollment
36
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2020
End Date
October 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Therapiezentrum Kinema

Eligibility Criteria

Inclusion Criteria

  • 18 to 98 years of age
  • Patients after an ischaemic or haemorraghic stroke at least 6 months prior to the start of the study
  • Limited ROM in the upper ankle joint dorsiflexion on the hemiparetic side: maximum 0° active ROM (aROM); maximum 5° of passive ROM (pROM)
  • Capability to independently transfer from a seating to a standing position without an assistive device while the use of the hands is allowed
  • Capability to independently walk without an assistive device for at least 10 metres
  • Confirmation of the principle investigator (PI) of the study (clinician) that there are no contraindications as to the exposure to an active training
  • Voluntary written informed consent

Exclusion Criteria

  • Any contraindication to manual therapy (ankle instability, ankle inflammation or traumas etc.)
  • Any not fully recovered injuries of the musculoskeletal system
  • Previous surgery in the lower extremity region leading to walking impairment due to orthopaedic reasons
  • Relevant ROM reduction of the hip or knee joints
  • Any cognitive or communication impairment hindering participation in this pilot study according to the study PI (dementia, severe aphasia, being under legal guardianship etc.)
  • Diabetes mellitus
  • Rheumatic diseases
  • Chronic pain treated by drug therapy
  • History of previous stroke with persistent, impairing neurological symptoms (as defined by a Modified Rankin Scale score (mRS) of \= 3\)
  • Comorbidity hindering participation in this pilot study, according to the study PI (life expectancy \<12 months, cancer, severe heart insufficiency etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials